Document Type : Review Article/ Systematic Review Article/ Meta Analysis
Authors
1 Department of Gastroenterology and Hepatology, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
2 Department of Anesthesiology, Razavi Hospital, Mashhad, Iran
3 Assistant Professor, Department of Cardiology, 9 Dey Educational Hospital, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
4 Department of Extra-Corporeal Circulation (ECC), Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
5 Department of Extra-Corporeal Circulation (ECC), Razavi Hospital, Mashhad, Iran
Abstract
Keywords
1. Strout N, Pasic L, Hicks C, Chua XY, Tashvighi N, Butler P, et al. The MothersBabies Study, an Australian Prospective Cohort Study Analyzing the Microbiome in the Preconception and Perinatal Period to Determine Risk of Adverse Pregnancy, Postpartum, and Child-Related Health Outcomes: Study Protocol. Int J Environ Res Public Health. 2023;20(18):6736. doi: 10.3390/ijerph20186736. [PubMed: 37754596]. https://doi.org/10.3390/ijerph20186736 PMid:37754596 PMCid:PMC10531411 |
||||
2. Anhê FF, Zlitni S, Zhang SY, Choi BS, Chen CY, Foley KP, et al. Human gut microbiota after bariatric surgery alters intestinal morphology and glucose absorption in mice independently of obesity. Gut. 2023;72(3):460-471. doi: 10.1136/gutjnl-2022-328185. [PubMed: 36008102]. https://doi.org/10.1136/gutjnl-2022-328185 PMid:36008102 PMCid:PMC9933168 |
||||
3. Zeng Z, Qiu J, Chen Y, Liang D, Wei F, Fu Y, et al. Altered Gut Microbiota as a Potential Risk Factor for Coronary Artery Disease in Diabetes: A Two-Sample Bi-Directional Mendelian Randomization Study. Int J Med Sci. 2024;21(2):376-395. doi: 10.7150/ijms.92131. [PubMed: 38169662]. https://doi.org/10.7150/ijms.92131 PMid:38169662 PMCid:PMC10758148 |
||||
4. Bai Y, Huang W, Jiang X, Xu W, Li Y, Wang Y, et al. Metabolomic interplay between gut microbiome and plasma metabolome in cardiac surgery-associated acute kidney injury. Rapid Commun Mass Spectrom. 2023;37(11):e9504. doi: 10.1002/rcm.9504. [PubMed: 36918294]. https://doi.org/10.1002/rcm.9504 PMid:36918294 |
||||
5. Amrein M, Li XS, Walter J, Wang Z, Zimmermann T, Strebel I, et al. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD). Clin Res Cardiol. 2022;111(6):692-704. doi: 10.1007/s00392-022-01992-6. [PubMed: 35220448]. https://doi.org/10.1007/s00392-022-01992-6 PMid:35220448 PMCid:PMC9151506 |
||||
6. Anhê FF, Varin TV, Schertzer JD, Marette A. The Gut Microbiota as a Mediator of Metabolic Benefits after Bariatric Surgery. Can J Diabetes. 2017;41(4):439-447. doi: 10.1016/j.jcjd.2017.02.002. [PubMed: 28552651]. https://doi.org/10.1016/j.jcjd.2017.02.002 PMid:28552651 |
||||
7. Magner C, Jenkins D, Koc F, Tan MH, O'Toole M, Boyle J, et al. Protocol for a prospective cohort study exploring the gut microbiota of infants with congenital heart disease undergoing cardiopulmonary bypass (the GuMiBear study). BMJ Open. 2023;13(3):e067016. doi: 10.1136/bmjopen-2022-067016. [PubMed: 37001916]. https://doi.org/10.1136/bmjopen-2022-067016 PMid:37001916 PMCid:PMC10069492 |
||||
8. Maekawa M, Yoshitani K, Yahagi M, Asahara T, Shishido Y, Fukushima S, Tadokoro N, Fujita T, Ohnishi Y. Association between postoperative changes in the gut microbiota and pseudopsia after cardiac surgery: prospective observational study. BMC Surg. 2020;20(1):247. doi: 10.1186/s12893-020-00907-4. [PubMed: 33081782]. https://doi.org/10.1186/s12893-020-00907-4 PMid:33081782 PMCid:PMC7576870 |
||||
9. Ding W, Liu J, Zhou X, Miao Q, Zheng H, Zhou B, et al. Clinical Multi-Omics Study on the Gut Microbiota in Critically Ill Patients After Cardiovascular Surgery Combined With Cardiopulmonary Bypass With or Without Sepsis (MUL-GM-CSCPB Study): A Prospective Study Protocol. Front Med (Lausanne). 2020;7:269. doi: 10.3389/fmed.2020.00269. [PubMed: 32733902]. https://doi.org/10.3389/fmed.2020.00269 PMid:32733902 PMCid:PMC7360671 |
||||
10. Xue L, Singla RK, Qin Q, Ding Y, Liu L, Ding X, et al. Exploring the complex relationship between vitamin K, gut microbiota, and warfarin variability in cardiac surgery patients. Int J Surg. 2023;109(12):3861-3871. doi: 10.1097/JS9.0000000000000673. [PubMed: 37598356]. https://doi.org/10.1097/JS9.0000000000000673 PMCid:PMC10720796 |
||||
11. Li Y, Jiang X, Chen J, Hu Y, Bai Y, Xu W, et al. Evaluation of the contribution of gut microbiome dysbiosis to cardiac surgery-associated acute kidney injury by comparative metagenome analysis. Front Microbiol. 2023;14:1119959. doi: 10.3389/fmicb.2023.1119959. [PubMed: 37065117]. https://doi.org/10.3389/fmicb.2023.1119959 PMid:37065117 PMCid:PMC10091463 |
||||
12. Pisano E, Bugli F, Severino A, Pedicino D, Paroni Sterbini F, Martini C, et al. Microbial signature of plaque and gut in acute coronary syndrome. Sci Rep. 2023;13(1):14775. doi: 10.1038/s41598-023-41867-y. [PubMed: 37679428]. https://doi.org/10.1038/s41598-023-41867-y PMid:37679428 PMCid:PMC10484905 |
||||
13. Li W, Zhou X, Yuan S, Wang L, Yu L, Sun J, et al. Exploring the Complex Relationship between Gut Microbiota and Risk of Colorectal Neoplasia Using Bidirectional Mendelian Randomization Analysis. Cancer Epidemiol Biomarkers Prev. 2023;32(6):809-817. doi: 10.1158/1055-9965.EPI-22-0724. [PubMed: 37012201]. https://doi.org/10.1158/1055-9965.EPI-22-0724 PMid:37012201 PMCid:PMC10233354 |
||||
14. Benson TW, Conrad KA, Li XS, Wang Z, Helsley RN, Schugar RC, et al. Gut Microbiota-Derived Trimethylamine N-Oxide Contributes to Abdominal Aortic Aneurysm Through Inflammatory and Apoptotic Mechanisms. Circulation. 2023;147(14):1079-1096. doi: 10.1161/CIRCULATIONAHA.122.060573. [PubMed: 37011073]. https://doi.org/10.1161/CIRCULATIONAHA.122.060573 PMid:37011073 PMCid:PMC10071415 |
||||
15. Carrillo-Salinas FJ, Anastasiou M, Ngwenyama N, Kaur K, Tai A, Smolgovsky SA, et al. Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling in a T cell-dependent manner. Gut Microbes. 2020;12(1):1-20. doi: 10.1080/19490976.2020.1823801. [PubMed: 33103561]. https://doi.org/10.1080/19490976.2020.1823801 PMid:33103561 PMCid:PMC7588211 |
||||
16. Allen SJ, Wareham K, Wang D, Bradley C, Sewell B, Hutchings H, et al. A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE). Health Technol Assess. 2013;17(57):1-140. doi: 10.3310/hta17570. [PubMed: 24309198]. https://doi.org/10.3310/hta17570 PMCid:PMC4781647 |
||||
17. Xiao J, Wei Z, Yang C, Dai S, Wang X, Shang Y. The gut microbiota in experimental abdominal aortic aneurysm. Front Cardiovasc Med. 2023;10:1051648. doi: 10.3389/fcvm.2023.1051648. [PubMed: 36910527]. https://doi.org/10.3389/fcvm.2023.1051648 PMid:36910527 PMCid:PMC9992639 |
||||
18. He X, Bai Y, Zhou H, Wu K. Akkermansia muciniphila Alters Gut Microbiota and Immune System to Improve Cardiovascular Diseases in Murine Model. Front Microbiol. 2022;13:906920. doi: 10.3389/fmicb.2022.906920. [PubMed: 35774450]. https://doi.org/10.3389/fmicb.2022.906920 PMid:35774450 PMCid:PMC9237526 |
||||
19. Wang XL, Chen WJ, Jin R, Xu X, Wei J, Huang H, et al. Engineered probiotics Clostridium butyricum-pMTL007-GLP-1 improves blood pressure via producing GLP-1 and modulating gut microbiota in spontaneous hypertension rat models. Microb Biotechnol. 2023;16(4):799-812. doi: 10.1111/1751-7915.14196. [PubMed: 36528874]. https://doi.org/10.1111/1751-7915.14196 PMid:36528874 PMCid:PMC10034621 |
||||
20. Wang L, Liu L, Liu X, Xiang M, Zhou L, Huang C, et al. The gut microbes, Enterococcus and Escherichia-Shigella, affect the responses of heart valve replacement patients to the anticoagulant warfarin. Pharmacol Res. 2020;159:104979. doi: 10.1016/j.phrs.2020.104979. [PubMed: 32505835]. https://doi.org/10.1016/j.phrs.2020.104979 PMid:32505835 |
||||
21. Kountouras J, Papaefthymiou A, Polyzos SA, Liatsos C, Tzitiridou-Chatzopoulou M, Chatzopoulos D, et al. Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease. Metabolism. 2022;135:155276. doi: 10.1016/j.metabol.2022.155276. [PubMed: 35940250]. https://doi.org/10.1016/j.metabol.2022.155276 PMid:35940250 |
||||
22. Efthymiou CA, Weir WI. Salmonella sepsis simulating gastrointestinal ischaemia following cardiopulmonary bypass. Interact Cardiovasc Thorac Surg. 2011;12(2):334-6. doi: 10.1510/icvts.2010.257972. [PubMed: 21106565]. https://doi.org/10.1510/icvts.2010.257972 PMid:21106565 |
||||
23. Lanuza F, Meroño T, Zamora-Ros R, Bondonno NP, Rostgaard-Hansen AL, Sánchez-Pla A, Miro B, Carmona-Pontaque F, Riccardi G, Tjønneland A, Landberg R, Halkjær J, Andres-Lacueva C. Plasma metabolomic profiles of plant-based dietary indices reveal potential pathways for metabolic syndrome associations. Atherosclerosis. 2023;382:117285. doi: 10.1016/j.atherosclerosis.2023.117285. [PubMed: 37778133]. https://doi.org/10.1016/j.atherosclerosis.2023.117285 PMid:37778133 |
||||
24. Osborn LJ, Schultz K, Massey W, DeLucia B, Choucair I, Varadharajan V, Banerjee R, Fung K, Horak AJ 3rd, Orabi D, Nemet I, Nagy LE, Wang Z, Allende DS, Willard BB, Sangwan N, Hajjar AM, McDonald C, Ahern PP, Hazen SL, Brown JM, Claesen J. A gut microbial metabolite of dietary polyphenols reverses obesity-driven hepatic steatosis. Proc Natl Acad Sci U S A. 2022 Nov 29;119(48):e2202934119. doi: 10.1073/pnas.2202934119. [PubMed: 36417437]. https://doi.org/10.1073/pnas.2202934119 PMid:36417437 PMCid:PMC9860326 |
||||
25. Xue L, Ding Y, Qin Q, Liu L, Ding X, Zhou Y, et al. Assessment of the impact of intravenous antibiotics treatment on gut microbiota in patients: Clinical data from pre-and post-cardiac surgery. Front Cell Infect Microbiol. 2023;12:1043971. doi: 10.3389/fcimb.2022.1043971. [PubMed: 36741975]. https://doi.org/10.3389/fcimb.2022.1043971 PMid:36741975 PMCid:PMC9896080 |
||||
26. Xue L, Ding Y, Qin Q, Liu L, Ding X, Zhou Y, et al. Assessment of the impact of intravenous antibiotics treatment on gut microbiota in patients: Clinical data from pre-and post-cardiac surgery. Front Cell Infect Microbiol. 2023;12:1043971. doi: 10.3389/fcimb.2022.1043971. [PubMed: 36741975]. https://doi.org/10.3389/fcimb.2022.1043971 PMid:36741975 PMCid:PMC9896080 |
||||
27. Zheng S, Shao S, Qiao Z, Chen X, Piao C, Yu Y, Gao F, Zhang J, Du J. Clinical Parameters and Gut Microbiome Changes Before and After Surgery in Thoracic Aortic Dissection in Patients with Gastrointestinal Complications. Sci Rep. 2017 Nov 9;7(1):15228. doi: 10.1038/s41598-017-15079-0. [PubMed: 29123168]. https://doi.org/10.1038/s41598-017-15079-0 PMid:29123168 PMCid:PMC5680333 |